Numerous studies indicate that IL-6 and its related signalling pathways have been identified to contribute to proliferation, migration, and invasion of various tumour cells [5–9] and its expression is associated with poor prognosis in many types of cancers [10–12]. The gene discussed is IL6; the disease is cancer.